www.xinhuanet.com
XINHUA online
CHINA VIEW
VIEW CHINA
 Breaking News Environment watchdog confirms northeastern river pollution    ROK parliament OKs plan to liberalize rice-market    Israel sets early election date    New Bird flu case found in western Canada     Gunman storms school in southeastern Turkey    At least 12 people killed in suicide bombing in northern Iraq    
Home  
China  
World  
Business  
Technology  
Opinion  
Culture/Edu  
Sports  
Entertainment  
Life/Health  
Travel  
Weather  
RSS  
  About China
  Map
  History
  Constitution
  CPC & Other Parties
  State Organs
  Local Leadership
  White Papers
  Statistics
  Major Projects
  English Websites
  BizChina
- Conferences & Exhibitions
- Investment
- Bidding
- Enterprises
- Policy update
- Technological & Economic Development Zones
Source Manufacturers and Suppliers from China and around the world
   News Photos Voice People BizChina Feature About us   
Clinical test of human bird flu vaccine gets go-ahead
www.chinaview.cn 2005-11-22 21:56:18

China's drug watchdog Tuesday approved its home-made human bird flu vaccine for clinical test, a major progress in China's prevention efforts of possible pandemic flu.
Resercher displays human vaccines for bird flu. (Xinhua)
    BEIJING, Nov. 22 (Xinhuanet) -- China's drug watchdog Tuesday approved its home-made human bird flu vaccine for clinical test, a major progress in China's prevention efforts of possible pandemic flu.

    The vaccine was developed from NIBRG-14 virus strain recommended and provided by the World Health Organization (WHO), according to the State Food and Drug Administration (SFDA).

    Pre-clinical trials show the vaccine is fairly safe and effective and the virus strain and the producing procedures of the vaccine are reliable, said SFDA experts.

    China began developing epidemic flu vaccine last year. SFDA has been monitoring the progress since its early stage. Fast-track examination procedures was granted to the vaccine after SFDA received application from the producer, according to SFDA.

    Beijing-based vaccine producer Sinovac Biotech, the first in the world to develop a SARS vaccine, applied to SFDA for clinical tests of the human bird flu vaccine in October. At present, the mass production for the vaccine is ready, said Yin Weidong, general manager of the company.

    China has so far reported 21 bird flu outbreaks in nine provinces, autonomous regions and municipalities, and has confirmed two human cases of bird flu. One victim in east China's Anhui Province has died and the other in central China's Hunan Province has recovered.

    Currently, seven other drug firms in the world, like those in the United States, the European Union and Japan, are also developing vaccines of this kind. Enditem

  Related Story
Shiseido ads beauties
Japan drafts new constitution for more assertive military
Zhao Wei's latest magazine photos
- CPC not pursuing a road of tyranny: scholar
- UN torture rapporteur visits China's prisons, praising openess
- China denies ordering Japan bullet trains
- Harbin cuts water supply for pollution fear; schools closed
- Customer splurges on three Airbus jets
- China has 383 mln mobile phone subscribers
- US Congressman says Bush visit to China successful
- Japan drafts new constitution for more assertive military
- Merkel starting 1st trip abroad as chancellor
- Kenyans reject new charter
- Hunger, malnutrition killing 6 mln children a year
- Israeli early election set for Mar. 28
- Danish troops may leave Iraq in 2006: US commander
- Poland to set timetable to join euro zone: PM
- Nestle recalls 2 mln liters of baby milk
- Russian PM cancels visit to Ukraine over gas row
Copyright ©2003 Xinhua News Agency. All rights reserved.
Reproduction in whole or in part without permission is prohibited.